CIN2000

Economic Aspects of Recombinant Human Erythropoietin in U.S. End-Stage Renal Disease Patients

Enrique Enrique C. Seoane Vázquez and Wendy St. Peter

USA

Go to the paper/Ir a la comunicación

Back to the congress' homepage/Volver al inicio del congreso